Search

everythinglearnresearchcommunity

for

Search:↓

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

Microneedling with either platelet-rich plasma or 5% minoxidil can increase hair growth in people with androgenetic alopecia, but minoxidil might be slightly better.

Oral cyclosporin doesn't stop hair loss.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Nonablative radiofrequency therapy improves hair density, thickness, and growth rate.

Optimal transplant density for Chinese male hair loss patients is 35-50 hair/cm², with minimum 106.88 hair/cm² left in donor area for esthetic satisfaction.

Hair loss affects self-esteem; patients seek effective, low side-effect treatments.

Non-ablative radio frequency can potentially increase hair count in men with androgenetic alopecia, but some may be bothered by the smell during treatment.

Extracts improve hair growth in alopecia.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

Homeopathy can effectively treat pattern hair loss by using remedies like Lycopodium Clavatum and Natrum Muriaticum, tailored to the patient's overall condition.

The combination of Stemoxydine® and Resveratrol improves hair density in women with Female Pattern Hair Loss.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

PRP therapy significantly improves hair thickness and density in male pattern baldness.

There is no significant link between male pattern baldness and insulin resistance.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

More personalized and effective treatments for androgenetic alopecia are needed.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Finasteride made hair thicker on the back of the head in men with hair loss.

AC5 improves hair loss and hair quality with high satisfaction rates.

Heat-treated Limosilactobacillus fermentum with menthol, salicylic acid, and panthenol promotes hair growth and balances scalp microbiome in people with androgenetic alopecia.

Androgenetic Alopecia (AGA) greatly lowers quality of life, causing stress and low self-esteem, with those seeking treatment experiencing more impairment.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.